Fig. 2
From: LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer
BC069792 inhibited the proliferative capacity of breast cancer cells. a The growth curve of CCK-8 assay showed that overexpression of BC069792 significantly inhibited the proliferation of MDA-MB-231 (P = 0.035) and MDA-MB-468 (P = 0.021) cells. b The results of EdU experiment showed that overexpression of BC069792 significantly inhibited the proliferation of MDA-MB-231 (P = 0.047) and MDA-MB-468 (P = 0.049) cells. c Overexpression of BC069792 inhibited the migration of MDA-MB-231 (P = 0.011) and MDA-MB-468 (P = 0.008) cells. It also inhibited the invasive ability of MDA-MB-231 (P = 0.020) and MDA-MB-468 (P = 0.006) cells (P < 0.05, P < 0.01, P < 0.001,. P < 0.0001, ns represent P > 0.05)**********